Optimizing Use of Oral Antibiotics in Acne Vulgaris

被引:34
作者
Del Rosso, James Q. [1 ]
Kim, Grace [1 ]
机构
[1] Valley Hosp Med Ctr, Las Vegas, NV 89106 USA
关键词
Oral antibiotics; Acne vulgaris; Antibiotic resistance; SUBANTIMICROBIAL-DOSE DOXYCYCLINE; PROPIONIBACTERIUM-ACNES; DOUBLE-BLIND; RESISTANT PROPIONIBACTERIA; TOPICAL TREATMENT; BENZOYL PEROXIDE; CLINDAMYCIN GEL; COMBINATION; ERYTHROMYCIN; AZITHROMYCIN;
D O I
10.1016/j.det.2008.07.006
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Oral antibiotics are commonly used to treat acne vulgaris, primarily in patients presenting with moderate to severe facial or truncal disease severity. These agents are most appropriately used in combination with a topical regimen containing benzoyl peroxide and a topical retinoid. The most common oral antibiotics for treating acne vulgaris are the tetracycline derivatives, although macrolide agents such as erythromycin have also been used extensively. Over the past 4 decades, as the sensitivity of Propionibacterium acnes to several oral and topical antibiotics has decreased, the efficacy of oral tetracycline and erythromycin has markedly diminished, leading to increased use of doxycycline, minocycline, and other agents, such as trimethoprim/sulfamethoxazole.
引用
收藏
页码:33 / +
页数:11
相关论文
共 62 条
[1]  
Amin Kathani, 2007, J Drugs Dermatol, V6, P873
[2]  
Bhambri S, 2007, CUTIS, V79, P430
[3]  
Bikowski Joseph B, 2003, Skinmed, V2, P234
[4]   Insights in the pathogenic potential of Propionibacterium acnes from its complete genome [J].
Brüggemann, H .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2005, 24 (02) :67-72
[5]  
Campbell James L Jr, 2007, J Drugs Dermatol, V6, P625
[6]   Systematic review of Propionibacterium acnes resistance to systemic antibiotics [J].
Cooper, AJ .
MEDICAL JOURNAL OF AUSTRALIA, 1998, 169 (05) :259-261
[7]  
Cunliffe WJ, 1999, BRIT J DERMATOL, V141, P757
[8]   A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris [J].
Cunliffe, WJ ;
Holland, KT ;
Bojar, R ;
Levy, SF .
CLINICAL THERAPEUTICS, 2002, 24 (07) :1117-1133
[9]  
Del Rosso J Q, 2000, Cutis, V66, P7
[10]  
Del Rosso James Q, 2007, J Drugs Dermatol, V6, P616